Dr. Radbel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Paterson Street
MEB 568
New Brunswick, NJ 08901Phone+1 732-235-7840Fax+1 732-235-7048
Summary
- I am a board certified physician who specializes in Pulmonary and Critical Care Medicine. My clinical interests are in the acute respiratory distress syndrome (ARDS), pulmonary fibrosis and pulmonary embolism. My research interests are in ozone pollution and World Trade Center Dust's effects on the pulmonary innate immune system.
Education & Training
- Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2017
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2011 - 2014
- American University of the Caribbean School of MedicineClass of 2014
Certifications & Licensure
- NJ State Medical License 2016 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Outstanding Fellow Award for Excellence in Teaching Rutgers Robert Wood Johnson Medical School, 2016
- Young Investigator Award American College of Chest Physicians, 2014
Publications & Presentations
PubMed
- 47 citationsMontelukast in hospitalized patients diagnosed with COVID-19.Ahsan R. Khan, Christian Misdary, Nikhil Yegya-Raman, Sinae Kim, Navaneeth Narayanan
The Journal of Asthma. 2021-03-04 - 327 citationsAssociation Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.Shruti Gupta, Wei Wang, Salim S. Hayek, Lili Chan, Kusum S. Mathews
JAMA Internal Medicine. 2021-01-01 - 643 citationsFactors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the USShruti Gupta, Salim S. Hayek, Wei Wang, Lili Chan, Kusum S. Mathews
JAMA Internal Medicine. 2020-11-01
Journal Articles
- Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USKusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Alexandre M Shehata, Nitender G..., JAMA Internal Medicine
Authored Content
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
Press Mentions
- Combination Therapy Quells COVID-19 Cytokine StormJuly 27th, 2020
- A Simple and Readily Available Saline Solution Can Reliably Transport COVID-19 Samples to Testing LabsMay 28th, 2020
- CHEST: Lower ARDS Mortality, PAH, Jerky LegsOctober 30th, 2014
Grant Support
- Role of Chronic Intermittent Hypoxia in the Pathophysiology of World Trade Center Dust DiseaseNIEHS2016–2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: